SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
SEC Accession No. 0001193125-05-194938
Filing Date
2005-09-30
Accepted
2005-09-30 15:30:58
Documents
8
Effectiveness Date
2005-09-30

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO.1 ds8pos.htm S-8 POS 44143
2 CONSENT OF ERNST & YOUNG LLP dex231.htm EX-23.1 3040
3 INKINE PHARMACEUTICAL COMPANY, INC. 1993 STOCK OPTION PLAN dex991.htm EX-99.1 26383
4 INKINE PHARMACEUTICAL COMPANY, INC. 1997 CONSULTANT STOCK OPTION PLAN dex992.htm EX-99.2 23955
5 INKINE PHARMACEUTICAL COMPANY, INC. 1999 EQUITY COMPENSATION PLAN dex993.htm EX-99.3 50933
6 INKINE PHARMACEUTICAL COMPANY, INC. 2004 EQUITY COMPENSATION PLAN dex994.htm EX-99.4 56916
7 OPTION TO PURCHASE SHARES OF COMMON STOCK (NO. LJ-1) dex995.htm EX-99.5 52204
8 OPTION TO PURCHASE SHARES OF COMMON STOCK (NO. LJ-2) dex996.htm EX-99.6 52116
  Complete submission text file 0001193125-05-194938.txt   311161
Mailing Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560
Business Address 1700 PERIMETER PARK DRIVE MORRISVILLE NC 27560 (919) 862-1000
SALIX PHARMACEUTICALS LTD (Filer) CIK: 0001009356 (see all company filings)

IRS No.: 943267443 | Fiscal Year End: 1231
Type: S-8 POS | Act: 33 | File No.: 333-126685 | Film No.: 051114111
SIC: 2834 Pharmaceutical Preparations